ALTIMMUNE, INC. Other Current Liabilities
ALTIMMUNE, INC. (ALT) had Other Current Liabilities of $11.59 thousand as of 2017-03-31, per its 10-Q filed 2017-05-03.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2017-05-03
- 2017-03-31: Other Liabilities, Current $11.59K.
- 2016-12-31: Other Liabilities, Current $11.59K.
- 2016-09-30: Other Liabilities, Current $11.59K.
- 2016-06-30: Other Liabilities, Current $11.59K.
| Period end | Other Liabilities, Current |
|---|---|
| 2017-03-31 | $11.59K 10-Q · filed 2017-05-03 |
| 2016-12-31 | $11.59K 10-Q · filed 2017-05-03 |
| 2016-09-30 | $11.59K 10-Q · filed 2016-11-04 |
| 2016-06-30 | $11.59K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-09 |
| 2015-12-31 | $11.25K 10-K · filed 2017-03-14 |
| 2015-06-30 | $74.23K 10-Q · filed 2015-08-05 |
| 2015-03-31 | $72.67K 10-Q · filed 2015-05-07 |
| 2014-12-31 | $70.33K 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |